Cargando…
Efficacy of a medical grade honey formulation (L-Mesitran) in comparison with fluconazole in the treatment of women with recurrent vulvovaginal candidiasis: protocol for a randomised controlled trial (HONEY STUDY)
INTRODUCTION: Recurrent vulvovaginal candidiasis (RVVC) affects up to 9% of women worldwide. This amount is expected to increase due to lifestyle changes, increased fungal resistance and biofilm formation. Treatment options are limited and in 57% of the cases, relapses occur within 12 months after s...
Autores principales: | van Riel, Senna J J M, Lardenoije, Céline M J G, Wassen, Martine M L H, van Kuijk, Sander M J, Cremers, Niels A J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462966/ https://www.ncbi.nlm.nih.gov/pubmed/37640455 http://dx.doi.org/10.1136/bmjopen-2022-070466 |
Ejemplares similares
-
Treating (Recurrent) Vulvovaginal Candidiasis with Medical-Grade Honey—Concepts and Practical Considerations
por: van Riel, Senna J. J. M., et al.
Publicado: (2021) -
Antifungal (oral and vaginal) therapy for recurrent vulvovaginal candidiasis: a systematic review protocol
por: Lírio, Juliana, et al.
Publicado: (2019) -
Vaginal hysterectomy versus vaginal assisted NOTES hysterectomy (VANH): a protocol for a randomised controlled trial
por: Bekkers, Ilse, et al.
Publicado: (2022) -
Comparison between Fluconazole with Oral Protexin Combination and Fluconazole in the Treatment of Vulvovaginal Candidiasis
por: Nouraei, S., et al.
Publicado: (2012) -
Corrigendum to “Comparison between Fluconazole with Oral Protexin Combination and Fluconazole in the Treatment of Vulvovaginal Candidiasis”
por: Nouraei, S., et al.
Publicado: (2017)